Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Mar 16;9(3):303–312. doi: 10.7150/ijbs.6214

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.

PMC Copyright notice

Fig 2 — Development of a template MIR26-DX to identify candidate HCC patients for adjuvant IFNα therapy based Cohort 1. (A) A schematic diagram of the MIR26-DX. A 6-point scoring system was developed based on the median miR-26 expression normalized to six reference transcripts in the Cohort 1 as described in the Method section. (B) The forest plot showing hazard ratios in log2 scale for the overall survival of HCC patients from Cohort 1 treated with IFNα versus controls without or with selection by the 6-point score system. (C) Kaplan-Meier survival curves showing the overall survival of HCC patients with low miR-26 (left) or high miR-26 (right) from Cohort 1 treated with or without IFNα. The number of cases under risk was listed.